Exhibitors & Products at MEDICA & COMPAMED

Please note: This is the preliminary exhibitor database 2023. Until the start of MEDICA / COMPAMED 2023 on 13 Nov 2023 many changes are still possible. Numerous exhibitors will be added.

MyOrganizer

Q-Physio

where it finds its best application is the Sport Medicine. Thanks to QMR Technology the injured athlete can be immediately subjected to the therapy, speeding...that a REGENERATIVE process is induced. Although Q-Physio is extremely valid in the treatment of acute, chronic and/or degenerative desease, another field

Product of: Telea Electronic Engineering s.r.l.

ACRO Biomedical, the Leader of Regenerative Medicine

27 Jul 2023 | ACRO Biomedical, a company which has opened up its visibility in the international market and attracted international biomedical companies and investment teams to carry out cross-border cooperation,

2023 Taiwan BIO Awards - Innovation of the Year

News of: ACRO Biomedical Co., Ltd.

ROUSSELOT B.V.

Son en Breugel, Netherlands

The biomaterial experts since 1891. Meet us to discuss about how gelatin can help improve your application in regenerative medicine,

ACRO Biomedical Co., Ltd.

Kaohsiung City, Taiwan

and regenerative medicine (TERM). ACRO Biomedical uses its proprietary supercritical CO₂ extraction technology to remove cells, fat, and non-collagenous proteins

Demcon Life Sciences & Health B.V.

Enschede, Netherlands

therapy, regenerative medicine and organ on a Chip. We master a wide range of disciplines, ranging from mechatronics, systems engineering and artificial

Foundation for Biomedical Research and Innovation at Kobe

Kobe, Japan

- Pharmaceutical and regenerative medicine companies - Universities - R&D support

Foundation for Biomedical Research and Innovation at Kobe

Semikal Teknoloji Sanayi ve Ticaret A.S.

Antalya, Türkiye

SEMICAL is a regenerative medicine company in TURKEY/TÜRKİYE that has conducted research and development activities for many years to develop

SLSBio Co., Ltd.

Suwon-si, Korea, Republic

NALF(Nucleic Acid Lateral Flow) before its commercialization. SLSBio Co., Ltd. is planning to invest in veterinary regenerative medicine using stem cells